What Determines HIV Prevention Costs at Scale? Evidence from the Avahan Programme in India.

Lépine, A; Chandrashekar, S; Shetty, G; Vickerman, P; Bradley, J; Alary, M; Moses, S; CHARME India Group; Vassall, A; , COLLABORATORS; +6 more... Blanchard, J; Isac, S; Lowndes, CM; Ramesh, BM; Reza-Paul, S; Washington, R; (2016) What Determines HIV Prevention Costs at Scale? Evidence from the Avahan Programme in India. Health economics, 25 Sup. pp. 67-82. ISSN 1057-9230 DOI: https://doi.org/10.1002/hec.3296

Permanent Identifier

Use this Digital Object Identifier when citing or linking to this resource.

https://doi.org/10.1002/hec.3296

Abstract

Share

Downloads

Filename: HEC-25-67.PMC5019264.pdf

Licence: Creative Commons: Attribution 3.0

Download
[img]

Filename: determinants of average cost revised without track changes.docx

Licence: Creative Commons: Attribution-Noncommercial-No Derivative Works 3.0

Download
[img]

Downloads

View details

Metrics & Citations


Google Scholar